DeepLife
Peter Revill is an experienced leader in product management and development within the life sciences and biotechnology sectors. Currently serving as the Head of Product at DeepLife since March 2025, Peter previously held the same position at Biorelate Ltd., where innovation through the Galactic AI platform was a focus. From March 2017 to January 2023, Peter was a Product Manager at Clarivate Analytics, driving advancements in the commercialization of life sciences ideas. During a decade at Thomson Reuters, Peter directed an international team of scientists in curating biological information essential for drug and diagnostics discovery. Peter's early career involved significant roles at Kosan Biosciences as a Senior Scientist and at The John Innes Centre as a Scientist, where expertise in genetics and microbiology was developed. Peter holds a PhD in Biochemistry from the University of Cambridge and a BSc in Microbiology from the University of Warwick.
This person is not in any teams
This person is not in any offices
DeepLife
DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, and proprietary deep learning-based cell engineering tools. Our goal is to supplement in vitro testing with in silico simulations and rapidly discover molecular triggers to efficiently engineer cell behavior. We are working closely with biotech and pharmaceutical companies to accelerate their target identification processes. We are also collaborating actively with the academic community by publishing papers and providing open access to our platform’s features and data.